Could cause temporary or reversible harm; serious harm is unlikely.
Presence of foreign substance: identified as aluminum.
| Brand name | SPIRONOLACTONE |
| Generic name | SPIRONOLACTONE |
| Active ingredient(s) | SPIRONOLACTONE |
| Distributed by / for | SUN PHARMACEUTICAL INDUSTRIES INC |
| NDC | 53489-143-01 |
| Full product label | Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | USA Nationwide |
| Quantity | 11,328 bottles |
| Recall initiated | 2025-08-05 |
| Report date | 2025-08-13 |
| Recall completed | — |
| Recall number | D-0574-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗